Robert Greevy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Quotable quotes heard by <em>MedPage Today</em>'s reporters

We haven't seen 'the best version of this device,' said panel member

A panel of external advisors to the U.S. Food and Drug Administration voted against Intarcia Therapeutics' diabetes treatment implant on Thursday, citing risks from potential side-effects. The committee unanimously held that the benefits of the drug-device combination for the treatment of type 2 diabetes did not outweigh its risks, pointing to the need for additional safety data. The decision comes on the back of two previous rejections by the health regulator owing to the drug's potential acute kidney injury (AKI) and cardiovascular risks.

Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, according to a new study published in JAMA Internal Medicine.

Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, according to a new study published in&nbsp;JAMA Internal Medicine.A team of Vanderbilt investigators led the study as part of the&nbsp;VA Million Veteran Program&nbsp;COVID-19 Science Initiative.The findings may explain some health disparities associated with COVID-19 and could guide efforts to identify individuals who are at increased risk of acute kidney injury ...